Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Modified Augmented BFM Therapy for Infants With Acute Lymphoblastic Leukemia

NCT00022126 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00022126
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00022126 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Modified Augmented BFM Therapy for Infants With Acute Lymphoblastic Leukemia
Lead sponsor
Children's Oncology Group
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2002
Completion date
April 30, 2006
Enrollment
6 (actual)
Sites
51

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia